Updated Review on Risk Management Strategies in Quality Assurance for the Pharmaceutical Industry

Quality assurance risk management (QRM) is a critical component of the pharmaceutical industry that is performed to ensure the product and process safety and regulatory compliance. This review presents the significance of risk assessment and its control strategies, supported with examples from past incidents (eg, heparin contamination crisis, product recalls) supporting the need for sound risk management practices. Specifically, GMP guidelines are in place to ensure that pharmaceutical companies adhere to correct quality standards to prevent the hindrance of manufacturing authorizations and marketing approvals for qualified companies. This review highlights risk assessment tools and methodologies that inform hazard/risks identification and mitigation and summarizes the regulatory landscape informing risk management. International Council for Harmonisation (ICH) has played a significant role in this area with the Q9 and Q10 guidelines that encourage a systematic, science-based approach to risk management across the product lifecycle from development through distribution. Adhering to these standards is not just critical for meeting regulatory requirements but also for upholding industry credibility and consumer confidence. The scope of these measures guarantees the quality of their products and, thus, improves public health. This review details the state-of-the-art and future aspects of pharmaceutical quality risk management, highlighting the requirements of regulatory standards. Ultimately, the establishment of sound risk management practices not only enhances the safety, efficacy, and reliability of pharmaceutical products but also helps regain the trust in the industry.